David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Helen of Troy
HELE
$666M
| $19.8M | 0.02% |
163,973
-66,286
| -29% | -$7.14M |
|
852
O-I Glass
OI
$1.11B
| $19.8M | 0.02% |
1,206,982
+786,260
| +187% | +$12.1M |
|
853
United Therapeutics
UTHR
$22B
| $19.7M | 0.02% |
89,699
+4,613
| +5% | +$1.06M |
|
854
Zimmer Biomet
ZBH
$19.3B
| $19.7M | 0.02% |
161,910
+72,252
| +81% | +$8.06M |
|
|
MRSH
855
Marsh
MRSH
$92.9B
| $19.7M | 0.02% |
103,990
+75,387
| +264% | +$14.6M |
|
856
Dow Inc
DOW
$22.7B
| $19.7M | 0.02% |
359,247
-557,440
| -61% | -$28.5M |
|
857
CALL
Fair Isaac
FICO
$25.2B
| $19.7M | 0.02% |
16,900
-39,900
| -70% | -$40.2M |
|
858
PUT
Philip Morris
PM
$298B
| $19.6M | 0.02% |
208,300
+73,300
| +54% | +$6.75M |
|
859
CALL
Wynn Resorts
WYNN
$10.2B
| $19.6M | 0.02% |
214,800
+14,400
| +7% | +$1.28M |
|
860
PUT
Nutrien
NTR
$35.5B
| $19.5M | 0.02% |
346,200
+123,900
| +56% | +$7M |
|
861
PUT
BioNTech
BNTX
$28.3B
| $19.5M | 0.02% |
184,600
| – | – |
|
|
HPP
862
Hudson Pacific Properties
HPP
$798M
| $19.5M | 0.02% |
298,804
+41,291
| +16% | +$1.82M |
|
863
American Homes 4 Rent
AMH
$12.5B
| $19.5M | 0.02% |
541,307
+126,683
| +31% | +$4.42M |
|
864
CALL
Peloton Interactive
PTON
$2.35B
| $19.4M | 0.02% |
3,190,600
| – | – |
|
865
PUT
EQT Corp
EQT
$33.6B
| $19.4M | 0.02% |
501,700
-139,800
| -22% | -$5.67M |
|
866
East-West Bancorp
EWBC
$17.7B
| $19.4M | 0.02% |
268,977
-39,129
| -13% | -$2.36M |
|
867
S&P Global
SPGI
$128B
| $19.3M | 0.02% |
43,915
+41,889
| +2,068% | +$16.5M |
|
868
Texas Pacific Land
TPL
$25.8B
| $19.2M | 0.02% |
110,142
+38,340
| +53% | +$7.29M |
|
869
Bio-Rad Laboratories Class A
BIO
$10.2B
| $19.2M | 0.02% |
59,354
+47,242
| +390% | +$14.8M |
|
870
SiriusXM
SIRI
$9.59B
| $19.1M | 0.02% |
348,875
+336,477
| +2,714% | +$16.2M |
|
|
AZPN
871
DELISTED
Aspen Technology Inc
AZPN
| $19M | 0.02% |
86,474
+58,345
| +207% | +$11.2M |
|
872
Shoals Technologies Group
SHLS
$1.14B
| $19M | 0.02% |
1,223,122
-78,838
| -6% | -$1.19M |
|
|
SKX
873
DELISTED
Skechers
SKX
| $19M | 0.02% |
304,572
-146,674
| -33% | -$7.9M |
|
874
Tradeweb Markets
TW
$22.9B
| $19M | 0.02% |
208,698
+70,468
| +51% | +$6.29M |
|
875
G-III Apparel Group
GIII
$1.43B
| $19M | 0.02% |
557,878
-135,073
| -19% | -$3.8M |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.